Loading institutional data...
Loading institutional data...
Strong institutional distribution: ownership decreased -5.21% quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $297.2M 100.0% | $266.3M 100.0% | $202.1M 100.0% | $148.6M 100.0% | $99.7M 100.0% | $56.5M 100.0% | $34.9M 100.0% | $0 | — |
| Cost of Revenue | $100.1M 33.7% | $84.0M 31.5% | $64.5M 31.9% | $58.8M 39.6% | $43.5M 43.7% | $18.3M 32.4% | $8.0M 22.9% | $0 | — |
| Gross Profit | $197.1M 66.3% | $182.3M 68.5% | $137.6M 68.1% | $89.8M 60.4% | — | — | $26.9M 77.1% | $0 | — |
| Research & Development | — | — | — | — | $2.1M 2.1% | $1.7M 3.0% | $4.0M 11.4% | $6.5M | $6.7M |
| Selling, General & Admin | $220.8M 74.3% | $198.0M 74.4% | $164.9M 81.6% | $141.8M 95.4% | $112.1M 112.4% | $98.2M 173.7% | $113.6M 325.2% | $29.1M | $4.8M |
| Total Operating Expenses | $229.8M 77.3% | $216.7M 81.4% | $186.8M 92.4% | $155.1M 104.4% | $144.1M 144.6% | $209.6M 370.7% | $125.9M 360.4% | $46.1M | $11.7M |
| Operating Income | -$32.7M -11.0% | -$34.4M -12.9% | -$49.2M -24.4% | -$65.3M -44.0% | -$44.4M -44.6% | -$153.1M -270.7% | -$98.9M -283.3% | -$46.1M | -$11.7M |
| Interest Expense | $19.7M 6.6% | $18.7M 7.0% | $13.8M 6.8% | $9.1M 6.1% | $1.4M 1.4% | — | — | $863K | $5K |
| Interest & Investment Income | — | — | — | — | — | — | — | $203K | $0 |
| Other Income (Expense), net | -$539K -0.2% | $127K 0.0% | $696K 0.3% | -$9K -0.0% | $0 0.0% | -$10.5M -18.6% | -$8.0M -22.8% | -$863K | — |
| Pretax Income | -$51.0M -17.1% | -$49.8M -18.7% | -$61.5M -30.4% | -$74.3M -50.0% | -$46.8M -46.9% | -$162.9M -288.2% | -$105.1M -300.8% | -$46.8M | -$11.7M |
| Income Tax Expense | $677K 0.2% | $664K 0.2% | $176K 0.1% | $95K 0.1% | $42K 0.0% | $77K 0.1% | -$15.0M -43.0% | $65K | -$7.3M |
| Net Income | -$51.6M -17.4% | -$50.4M -18.9% | -$61.7M -30.5% | -$74.4M -50.1% | -$46.8M -47.0% | -$163.0M -288.3% | -$90.0M -257.8% | -$46.9M | -$4.5M |
| Per Share | |||||||||
| EPS (Basic) | $-0.80 | $-0.81 | $-1.08 | $-1.33 | $-0.94 | $-4.83 | — | — | — |
| EPS (Diluted) | $-0.80 | $-0.81 | $-1.08 | $-1.33 | $-0.94 | $-4.83 | — | — | — |
| Weighted Avg Shares (Basic) | 64.5M | 62.0M | 56.9M | 56.1M | 49.8M | 33.7M | — | — | — |
| Weighted Avg Shares (Diluted) | 64.5M | 62.0M | 56.9M | 56.1M | 49.8M | 33.7M | — | — | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$46M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 9 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -42%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 9 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $54M covers the $0 due within a year 53826000.0× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~13.5% on $146M of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
EOD close · as of 2026-09-17
Where each multiple sits in its own 8-yr range · 14th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 8-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Returns are margin-driven, not leverage-driven — higher quality.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | — | 22.9 | 32.4 | 43.7 | 39.6 | 31.9 | 31.5 | 33.7 |
| Gross Profit | — | 77.1 | — | — | 60.4 | 68.1 | 68.5 | 66.3 |
| R&D | — | 11.4 | 3.0 | 2.1 | — | — | — | — |
| SG&A | — | 325.2 | 173.7 | 112.4 | 95.4 | 81.6 | 74.4 | 74.3 |
| Operating Income | — | -283.3 | -270.7 | -44.6 | -44.0 | -24.4 | -12.9 | -11.0 |
| Income Tax | — | -43.0 | 0.1 | 0.0 | 0.1 | 0.1 | 0.2 | 0.2 |
| Net Income | — | -257.8 | -288.3 | -47.0 | -50.1 | -30.5 | -18.9 | -17.4 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on EOLS: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 1085 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCAX | $1.24T | — | — | — | — | — | — | -34.4% | -34.4% | — | 143 |
| LLY | $1.03T | 50.2× | — | 15.9× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $894.1B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $650.5B | 24.5× | — | 6.9× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $467.1B | 111.9× | 33.4× | 7.6× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| MRK | $368.2B | 20.2× | — | 5.7× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| UNH | $339.9B | 28.4× | 19.7× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| AZN | $257.7B | — | — | — | — | — | — | — | — | — | 1,248 |
| TMO | $248.2B | 37.1× | 31.9× | 5.6× | 3.9% | — | 15.0% | 12.6% | 7.0% | 4.9× | 2,481 |
| AMGN | $204.6B | 26.7× | 17.6× | 5.6× | 10.0% | 67.2% | 21.0% | 89.1% | 12.2% | 3.8× | 3,014 |
| GILD | $187.3B | 22.3× | 20.4× | 6.4× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| ABT | $178.0B | 27.5× | 19.2× | 4.0× | 5.7% | 56.4% | 14.7% | 12.5% | 10.0% | 1.4× | 2,964 |
| PFE | $157.1B | 20.3× | — | 2.5× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $150.2B | 42.1× | 31.0× | 6.1× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $136.2B | 48.7× | 37.5× | 13.5× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| VRTX | $131.1B | 33.7× | 28.8× | 10.9× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| BMY | $127.8B | 18.2× | — | 2.6× | -0.2% | 71.1% | 14.6% | 38.2% | 11.1% | — | 2,431 |
| MDT | $118.8B | 24.9× | 12.6× | 3.3× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| CVS | $114.7B | 64.9× | 11.5× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| SYK | $107.1B | 33.4× | 18.4× | 4.3× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| MCK | $102.5B | 22.9× | 16.2× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| HCA | $96.4B | 15.1× | — | 1.3× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $91.4B | 16.4× | 15.5× | 0.5× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| REGN | $82.6B | 19.0× | 19.8× | 5.8× | 1.0% | — | 31.4% | 14.4% | 13.6% | 0.5× | 1,336 |
| CI | $72.7B | 12.4× | 5.5× | 0.3× | 11.2% | 21.8% | 2.2% | 14.3% | 14.1% | 0.0× | 1,583 |
| EOLS | $521M | — | — | 1.8× | 11.6% | 66.3% | -17.4% | 223% | -42.0% | -5.8× | 146 |
Peers = companies sharing EOLS's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.